ArticleCase reports in hematology2020

Prolonged Response of a Patient with Relapsed Acute Myeloid Leukemia to a Novel Oral Bromodomain Extraterminal Inhibitor (BETi).

Meilen Chang Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.